People in the News: Daniel Geffken, Alan Dunton, June Ameen, Pritesh Gandhi, Laura Sepp-Lorenzino, Victor Dzau | GenomeWeb

Marina Biotech announced that it has appointed Daniel Geffken as its interim CFO as it works to restart drug-development operations after halting operations in mid-2012 amid a cash shortfall. Geffken is managing director at Danforth Advisors.

Marina has also brought back former executives Alan Dunton as chief medical officer and June Ameen as senior vice president of program management and strategic alliances. Both will work for Marina on a consulting basis, helping it to restart development of its suspended Phase I familial adenomatous polyposis program.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.